Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD (300534.SZ) SHZ

Currency In CNY

AD

Valuation

Market Cap2.88B
Enterprise Value2.79B
P/E Ratio171.65
PEG Ratio-5.9
Price/Sales Ratio4.91
Price/Book Ratio4.84
Enterprise/Revenue4.81
Enterprise/EBITDA41.09

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.03
Operating Margin0.09
AD

Management Effectiveness

Return On Assets0.02
Return On Equity0.03

Income Statement

Revenue877.85M
Revenue/Share2.29
Gross Profit584.11M
EBITDA126.91M
Net Income43.95M
Diluted EPS0.14

Balance Sheet

Total Cash210.76M
Total Cash/Share0.69
Total Debt139.25M
Total Debt/Equity0.2
Current Ratio1.6
Book Value Per Share2.61

Price History

52-Week Change8.79
52-Week High20.96
52-Week Low6.78
Moving Average 50 Days11.91
Moving Average 200 Days10.76

Statistics

Average Volume47.24M
Shares Outstanding303.35M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.04
Trailing Annual Dividend Yield0.36
Payout Ratio0.07
Last Split Factor7:2
Last Split DateMay 10, 2017
AD